← Back to results

◐ Forecasted · FOR-FD-25-014

NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens

Food and Drug Administration  ·  HHS

CFDA Numbers

93.103

Award Ceiling

$4.5M

Award Floor

Expected Awards

30

Close Date

Section I

How to Apply

View on grants_gov ↗

Program Contact


terrin.brown@fda.hhs.gov
2404027610

Section II

Eligibility

Eligible Applicant Types

00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 99

Section III

Description

This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats. The purpose of this FOA is to protect and promote public health by enhancing, strengthening and sustaining antibiotic resistance monitoring in retail food specimens within the NARMS program. The NARMS cooperative agreements is intended to improve the detection of antibiotic resistance among bacteria in food commodities, as well as expand to new sites to expand the scope of sampling. Measurable outcomes of the program will be in alignment with the NARMS Objectives.